UnknownNot Applicable

TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation

Germany32 participantsStarted 2020-08-13

Plain-language summary

The primary goal of the TCD-REDUCE study is to demonstrate the effectiveness of continuous transcranial Doppler sonography ("sonolysis") on the reduction of the ischemic stroke volume during MitraClip implantation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients with mitral regurgitation that are assigned to the MitraClip implantation by an interdisciplinary heart team according to current guidelines. Exclusion Criteria: * contraindication to MRI examination (e.g. pace-maker, implanted metal material, claustrophobia) * pregnancy * unable to consent * no transtemporal window

What they're measuring

stroke volume

Timeframe: 0-5 days after the MitraClip Implantation

Trial details

NCT IDNCT04384198

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09

Contact for this trial

Tim Bastian Braemswig, MD

+49 30 450560624 tim-bastian.braemswig@charite.de

View on ClinicalTrials.gov More Mitral Valve Insufficiency trials